TransMedics (TMDX) Current Assets (2018 - 2026)

TransMedics' Current Assets history runs 9 years deep, the most recent figure standing at $619.3 million for Q1 2026.

• On a quarterly basis, Current Assets rose 22.41% year-over-year to $619.3 million in Q1 2026; TTM through Mar 2026 was $619.3 million, a 22.41% increase from a year earlier, with the FY2025 full-year figure at $637.8 million, up 28.27% from the prior year.
• Current Assets retreated to $619.3 million in Q1 2026 per TMDX's latest filing, from $637.8 million in the prior quarter.
• Across five years, Current Assets topped out at $662.7 million in Q2 2023 and bottomed at $95.1 million in Q2 2022.
• The 5-year median for Current Assets is $505.9 million (2025), against an average of $446.9 million.
• Across the five-year window, Current Assets decreased 29.57% in 2022 and soared 596.7% in 2023, its largest moves.
• Year by year, Current Assets stood at $252.3 million in 2022, then soared by 102.4% to $510.7 million in 2023, then fell by 2.63% to $497.2 million in 2024, then advanced by 28.27% to $637.8 million in 2025, then decreased by 2.9% to $619.3 million in 2026.
• Per Business Quant, the three latest TMDX Current Assets figures stand at $619.3 million (Q1 2026), $637.8 million (Q4 2025), and $613.0 million (Q3 2025).